Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Entertainment Insider.
Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update
GlobeNewswire, Inc.
·
May 7, 2025
Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increase Product Revenues in the first in the first quarter of 2025 reached $109.9 million, compared to...
Green Methanol Market to Hit $23.19B by 2032, Driven by Decarbonization and Clean Energy Demand | DataM Intelligence
EIN Presswire
·
June 10, 2025
Green Methanol Market surges as industries adopt carbon-neutral fuels. Driven by clean tech, it's set to exceed $23B by 2032. NEW YORK, NY, UNITED STATES, June 10, 2025 /EINPresswire.com/ -- Market Overview : Green Methanol Market is emerging as...
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
GlobeNewswire, Inc.
·
March 7, 2025
REYKJAVIK, Iceland, March 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Barclays...
Oculis Publishes Invitation to the Annual General Meeting
GlobeNewswire, Inc.
·
May 9, 2025
ZUG, Switzerland, May 09, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), today published the invitation to the 2025 Annual General Meeting, which will be held on June 4, 2025 at Ochsen-Zug, Kolinplatz 11,...
Oculis Reports Q1 2025 Financial Results and Provides Company Update
GlobeNewswire, Inc.
·
May 8, 2025
The recent R&D Day (replay) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high unmet medical need, thanks to Privosegtor’s (OCS-05)...
Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
GlobeNewswire, Inc.
·
May 5, 2025
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of April 30, 2025 SELARSDI is approved for all...
Oculis to Present at Upcoming May Investor Conferences
GlobeNewswire, Inc.
·
May 7, 2025
ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
European Commission Approves Duvyzat for the Treatment of Duchenne Muscular Dystrophy
GlobeNewswire, Inc.
·
June 6, 2025
Now approved in the EU, Duvyzat offers an important treatment option for delaying Duchenne muscular dystrophy (DMD) disease progression Duvyzat is an orally administered treatment for DMD in patients 6 years and older who are able to walk The...
Contentstack Delivers Industry-First Real-Time Audience Insights Native in the CMS, Powering Adaptive Digital Experiences
GlobeNewswire, Inc.
·
June 4, 2025
AUSTIN, Texas, June 04, 2025 (GLOBE NEWSWIRE) -- Contentstack, the headless CMS pioneer and category disruptor in digital experiences, today unveiled Contentstack Data and Insights, a native set of capabilities for audience analytics and real-time...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
GlobeNewswire, Inc.
·
February 18, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences
GlobeNewswire, Inc.
·
May 1, 2025
ZUG, Switzerland, May 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet...
Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
GlobeNewswire, Inc.
·
March 18, 2025
HYDERABAD, India and REYKJAVIK, Iceland, March 18, 2025 (GLOBE NEWSWIRE) -- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “Dr. Reddy’s”) and Alvotech...
Century Applauds President Trump’s Aluminum Tariff Increase
GlobeNewswire, Inc.
·
June 2, 2025
CHICAGO, June 02, 2025 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) applauds President Trump’s unwavering defense of the nation’s domestic production of critical metals by increasing aluminum tariffs to 50 percent. President Trump’s...
ZA Miner Enhances Cloud Mining Platform with Flexible Contracts and Automated Payout Architecture
GlobeNewswire, Inc.
·
June 2, 2025
ZA Miner’s new flexible contracts and automated mining systems broaden secure access to regulated crypto earnings. Image by ZA Miner MIDDLESEX, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE) -- ZA Miner, a United Kingdom-based cloud mining...
Special Olympics World Winter Games Turin 2025 – Largest Sports and Humanitarian Event of the Year – Draw to a Close
GlobeNewswire, Inc.
·
March 16, 2025
• Eight sport disciplines • 100 delegations • 1,500 athletes and Unified partners TURIN, Italy, March 16, 2025 (GLOBE NEWSWIRE) -- Special Olympics World Winter Games Turin 2025, the largest sports and humanitarian event of the year, drew to a...
Oculis Hosts R&D Event Today to Showcase Progress on All Three Pipeline Assets
GlobeNewswire, Inc.
·
April 15, 2025
ZUG, Switzerland, April 15, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company"), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with...
QFSCOIN Launches Affordable Cloud Mining Contracts to Democratize Bitcoin Access
GlobeNewswire, Inc.
·
May 30, 2025
Lewes, Delaware, May 30, 2025 (GLOBE NEWSWIRE) -- QFSCOIN, a Delaware-based regulated cloud mining platform, today announced the launch of its affordable Bitcoin, Litecoin, and Dogecoin cloud mining contracts—eliminating the traditional barriers...
UK wants permanent Arctic army existence
MENAFN
·
May 29, 2025
(MENAFN) The UK government is reportedly considering the possibility of creating a permanent military presence in the Arctic in response to perceived threats from Russia, according to The Telegraph. This move is believed to be under consideration...
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
GlobeNewswire, Inc.
·
January 27, 2025
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals,...
AirAsia partners with Plan3 to transform the passenger experience during flight disruptions
EIN Presswire
·
February 13, 2025
Enhancing Passenger Support with Innovative Disruption Management Solutions. REYKJAVIK, 105, ICELAND, February 13, 2025 /EINPresswire.com/ -- Flight delays and cancellations affect hundreds of millions of passengers each year, costing the global...